Hepatic Impairment/Liver Disease (Severe)

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

1

Condition

Liver Disorders

Liver Failure

Treatment

N/A

Clinical Study ID

TX238355
  • Ages 18-75
  • All Genders

Study Summary

Single-Dose Study to Evaluate the Pharmacokinetics in Subjects with Normal and Impaired Hepatic Function.

Eligibility Criteria

Inclusion

  • Male or Non-pregnant/Non-lactating Females
  • Subjects ages 18-75 years old
  • Healthy weight

Study Design

Study Start date:
Estimated Completion Date:

Study Description

Connect with a study center

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.